HealthcareServices

Tumor Profiling Market Trends and Insights: Global Forecast to 2030

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the tumor profiling market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Tumor Profiling Market in 2030?

The tumor profiling market has experienced substantial expansion recently. This market is projected to increase from $11.18 billion in 2025 to $12.31 billion in 2026, at a compound annual growth rate (CAGR) of 10.1%. The historical growth of this market can be attributed to several factors, including an uptick in cancer incidence rates, the proliferation of molecular diagnostics laboratories, the growing application of targeted cancer therapies, improvements in sequencing technologies, and increased funding for oncology research.

The tumor profiling market is projected for substantial expansion in the coming years, with its size expected to reach $17.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This anticipated growth during the forecast period is primarily fueled by factors such as the increasing embrace of precision oncology, a rising demand for individualized cancer treatments, continuous advancements in bioinformatics platforms, the broader expansion of companion diagnostics, and increased investments in translational cancer research. Major trends expected to shape the market in this period include the greater adoption of next-generation sequencing, an increase in the use of multi-omics profiling approaches, the growing integration of AI-based data interpretation, the proliferation of personalized oncology applications, and a sharpened focus on biomarker discovery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

What Drivers Are Influencing Production Trends In The Tumor Profiling Market?

The increasing need for personalized medicine is projected to propel the expansion of the tumor profiling market in the future. This approach, known as personalized medicine, involves customizing healthcare treatments based on each patient’s unique characteristics. Patients are fueling this demand by seeking more targeted therapies, which promise improved results and reduced adverse effects when contrasted with conventional treatments. Tumor profiling aids personalized medicine by pinpointing particular genetic mutations and biomarkers within a patient’s tumor, thereby facilitating targeted interventions and minimizing unwanted side effects. For example, data from February 2024, sourced from a report by the Personalized Medicine Coalition, a US-based entity focused on promoting personalized medicine, revealed that personalized medicines constituted more than one-third of all new drug approvals in 2023, continuing this trend for the fourth consecutive year. Consequently, the expanding requirement for personalized medicine is accelerating the growth of the tumor profiling market.

Which Segments Are Gaining Traction In The Tumor Profiling Market?

The tumor profiling market covered in this report is segmented –

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics

2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray

3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting

3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)

What Trends Are Expected To Impact The Competitive Landscape Of The Tumor Profiling Market?

Leading firms within the tumor profiling market are concentrating on creating sophisticated tools, including artificial intelligence (AI)-driven diagnostic solutions, to improve the precision and effectiveness of cancer therapy. Artificial intelligence (AI) involves applying advanced computational techniques to analyze intricate genomic, proteomic, and clinical information, thereby facilitating quicker diagnoses, customized treatment plans, and improved tracking of disease advancement. Illustratively, in January 2025, Panakeia Technologies LTD, a UK-based enterprise focused on AI-powered software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-powered software solution is specifically engineered to analyze crucial molecular biomarkers such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR) directly from H and E-stained images of colon cancer tissue samples. This innovative digital instrument allows for swift and precise molecular profiling of tumors, which is vital for diagnosing colorectal cancer, detecting instances of Lynch syndrome, and guiding tailored treatment choices.

Who Are The Prominent Global Companies Shaping The Tumor Profiling Market Landscape?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Which Region Currently Holds The Largest Share Of The Tumor Profiling Market?

North America was the largest region in the tumor profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Tumor Profiling Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

Browse Through More Reports Similar to the Global Tumor Profiling Market 2026, By The Business Research Company

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Cancer Profiling Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795